Cambrex Corporation is a life sciences company that provides products and services for small molecule active pharmaceutical ingredients (APIs). The company's products and services are used in the development and commercialization of new and generic therapeutics. Cambrex operates through three segments: Small Molecule API, Biologic API, and Finished Dosage Formulations. The Small Molecule API segment provides APIs for branded and generic drugs, while the Biologic API segment provides biologically derived APIs. The Finished Dosage Formulations segment provides finished dosage forms of solid, semi-solid, and liquid products. Cambrex serves customers in the United States, Europe, and Asia.